155 related articles for article (PubMed ID: 32989170)
1. Hormonal contraception and risk of STIs and bacterial vaginosis in South African adolescents: secondary analysis of a randomised trial.
Balle C; Gill K; Konstantinus IN; Jaumdally SZ; Lennard K; Esra R; Happel AU; Barnabas SL; Gamieldien H; Pidwell T; Maseko V; Lesosky M; Myer L; Passmore JS; Bekker LG; Jaspan HB
Sex Transm Infect; 2021 Mar; 97(2):112-117. PubMed ID: 32989170
[TBL] [Abstract][Full Text] [Related]
2. Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial.
Balle C; Konstantinus IN; Jaumdally SZ; Havyarimana E; Lennard K; Esra R; Barnabas SL; Happel AU; Moodie Z; Gill K; Pidwell T; Karaoz U; Brodie E; Maseko V; Gamieldien H; Bosinger SE; Myer L; Bekker LG; Passmore JS; Jaspan HB
Nat Commun; 2020 Nov; 11(1):5578. PubMed ID: 33149114
[TBL] [Abstract][Full Text] [Related]
3. Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia.
Shipitsyna E; Khusnutdinova T; Budilovskaya O; Krysanova A; Shalepo K; Savicheva A; Unemo M
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1221-1230. PubMed ID: 32036466
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
Dabee S; Tanko RF; Brown BP; Bunjun R; Balle C; Feng C; Konstantinus IN; Jaumdally SZ; Onono M; Nair G; Palanee-Phillips T; Gill K; Baeten JM; Bekker LG; Passmore JS; Heffron R; Jaspan HB; Happel AU
Front Immunol; 2021; 12():760504. PubMed ID: 34956191
[TBL] [Abstract][Full Text] [Related]
5. Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array.
Taku O; Onywera H; Mbulawa ZZA; Businge CB; Meiring TL; Williamson AL
Microbiol Spectr; 2022 Jun; 10(3):e0222921. PubMed ID: 35647888
[TBL] [Abstract][Full Text] [Related]
6. Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combined Contraceptive Vaginal Rings.
Konstantinus IN; Balle C; Jaumdally SZ; Galmieldien H; Pidwell T; Masson L; Tanko RF; Happel AU; Sinkala M; Myer L; Bosinger SE; Gill K; Bekker LG; Jaspan HB; Passmore JS
Clin Infect Dis; 2020 Oct; 71(7):e76-e87. PubMed ID: 31675420
[TBL] [Abstract][Full Text] [Related]
7. Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections.
Balkus JE; Manhart LE; Lee J; Anzala O; Kimani J; Schwebke J; Shafi J; Rivers C; Kabare E; Scott McClelland R
J Infect Dis; 2016 Jun; 213(12):1932-7. PubMed ID: 26908758
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
Myer L; Denny L; Wright TC; Kuhn L
Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
[TBL] [Abstract][Full Text] [Related]
9. Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV.
Barnabas SL; Dabee S; Passmore JS; Jaspan HB; Lewis DA; Jaumdally SZ; Gamieldien H; Masson L; Muller E; Maseko VD; Mkhize N; Mbulawa Z; Williamson AL; Gray CM; Hope TJ; Chiodi F; Dietrich J; Gray G; Bekker LG;
Int J STD AIDS; 2018 May; 29(6):531-539. PubMed ID: 29198180
[TBL] [Abstract][Full Text] [Related]
10. Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women.
Garrett N; Mtshali A; Osman F; Masson L; McKinnon LR; Singh R; Mitchev N; Ngobese H; Kharsany ABM; Abdool Karim S; Mlisana K; Passmore JA; Rompalo A; Mindel A; Liebenberg L
Sex Transm Infect; 2021 Dec; 97(8):555-565. PubMed ID: 33608480
[TBL] [Abstract][Full Text] [Related]
11. Use of injectable progestin contraception and risk of STI among South African women.
Pettifor A; Delany S; Kleinschmidt I; Miller WC; Atashili J; Rees H
Contraception; 2009 Dec; 80(6):555-60. PubMed ID: 19913149
[TBL] [Abstract][Full Text] [Related]
12. The two-sided role of the vaginal microbiome in Chlamydia trachomatis and Mycoplasma genitalium pathogenesis.
Molenaar MC; Singer M; Ouburg S
J Reprod Immunol; 2018 Nov; 130():11-17. PubMed ID: 30149363
[TBL] [Abstract][Full Text] [Related]
13. Associations between intravaginal practices and incidence of sexually transmitted infections and bacterial vaginosis among women enrolled in the dapivirine vaginal ring trial (The Ring Study) in southwestern Uganda: a retrospective secondary analysis.
Kusemererwa S; Ruzagira E; Onyango M; Kabarambi A; Abaasa A
BMJ Open; 2024 Apr; 14(4):e079497. PubMed ID: 38589266
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women.
Kiweewa FM; Brown E; Mishra A; Nair G; Palanee-Phillips T; Mgodi N; Nakabiito C; Chakhtoura N; Hillier SL; Baeten JM;
J Int AIDS Soc; 2019 Feb; 22(2):e25257. PubMed ID: 30816632
[TBL] [Abstract][Full Text] [Related]
15. Impact of contraceptive initiation on vaginal microbiota.
Achilles SL; Austin MN; Meyn LA; Mhlanga F; Chirenje ZM; Hillier SL
Am J Obstet Gynecol; 2018 Jun; 218(6):622.e1-622.e10. PubMed ID: 29505773
[TBL] [Abstract][Full Text] [Related]
16. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives.
Harryparsad R; Meyer B; Taku O; Serrano M; Chen PL; Gao X; Williamson AL; Mehou-Loko C; d'Hellencourt FL; Smit J; Strauss J; Nanda K; Ahmed K; Beksinska M; Buck G; Morrison C; Deese J; Masson L
PLoS One; 2023; 18(11):e0294285. PubMed ID: 37948399
[TBL] [Abstract][Full Text] [Related]
18. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.
Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK
Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.
Torrone EA; Morrison CS; Chen PL; Kwok C; Francis SC; Hayes RJ; Looker KJ; McCormack S; McGrath N; van de Wijgert JHHM; Watson-Jones D; Low N; Gottlieb SL;
PLoS Med; 2018 Feb; 15(2):e1002511. PubMed ID: 29485986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
